Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC):results from the phase 2 GEOMETRY mono-1 study.

Authors
Publication date
20 May 2020
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Groningen

    redirect
    oaioai:pure.rug.nl:publications/1...
    Last time updated on 24/11/2020